ITP refers to primary immune thrombocytopenia, which is an acquired autoimmune disease and is a bleeding disorder caused by factors such as thrombocytopenia.
ITP is the acronym of primary immune thrombocytopenia, which is mainly caused by excessive autoimmune-mediated platelet destruction or decreased platelet production, and the overall performance is a hemorrhagic disease caused by decreased platelets in the body, and the main bleeding sites are skin and mucous membranes, which are manifested as petechiae in the distal limbs and mucous membrane hemorrhage, which need to be judged comprehensively through clinical examination.
Primary immune thrombocytopenia ITP is mainly diagnosed through routine blood tests, bone marrow tests and anti-platelet antibody measurements. After the diagnosis of the disease is confirmed, it is treated with hormones (prednisone, etc.), immunological agents (cyclophosphamide, etc.), eltrombopagide, and gammaglobulin, and in severe cases, it can be treated with splenectomy.
The presence of obvious generalized ecchymosis or abnormal thrombocytopenia requires prompt medical attention and standardized diagnosis and treatment under the guidance of clinicians to avoid delays.